→Arg substitution (hIgG1-G396R), which positively correlates with systemic lupus erythematosus. In induced lupus models, murine homolog Gly 390 →Arg (G390R) knockin mice generate excessive numbers of plasma cells, leading to a burst of broad-spectrum autoantibodies. This enhanced production of antibodies is also observed in hapten-immunized G390R mice, as well as in influenza-vaccinated human G396R homozygous carriers. This variant potentiates the phosphorylation of the IgG1 immunoglobulin tail tyrosine (ITT) motif. This, in turn, alters the availability of phospho-ITT to trigger longer adaptor protein Grb2 dwell times in immunological synapses, leading to hyper-Grb2-Bruton's tyrosine kinase (Btk) signaling upon antigen binding. Thus, the hIgG1-G396R variant is important for both lupus pathogenesis and antibody responses after vaccination.
A utoimmune diseases such as systemic lupus erythematosus (SLE) are characterized by the presence of large numbers of selfreactive antibodies that induce deposition of immune complexes (ICs), leading to inflammation and tissue damage (1) . Autoreactivity is pervasive in the antibody repertoire of human B cells across different developmental stages (2) . It is especially enriched in the peripheral immunoglobulin G-positive (IgG + ) memory B cell pool but is efficiently diminished in the plasma cell compartment in healthy individuals (2) (3) (4) . However, these checkpoints fail in patients with autoimmune diseases. It remains unclear how autoreactive IgG + B cells are maintained in a quiescent state under physiological immune homeostasis and how these checkpoints are broken in pathological conditions. IgG-B cell receptor (IgG-BCR) potently enhances memory IgG antibody responses via the evolutionarily conserved cytoplasmic tail of membrane-bound IgG (mIgG-tail) (5-10). The mIgG-tail amplifies BCR signaling via its phospho-immunoglobulin tail tyrosine (ITT) motif, which recruits the adaptor protein Grb2 to enhance Ca 2+ mobilization, synergistically with Bruton's tyrosine kinase (Btk) and phospholipase C-g2 (PLC-g2) (5, 11) .
Here we identified a single-nucleotide polymorphism (SNP) rs117518546, which results in a glycine-to-arginine substitution at codon 396 in human IgG1 (hIgG1-G396R) (fig. S1A and table S1). This SNP was common in East Asian populations (fig. S1B) and was significantly correlated with susceptibility to SLE (tables S2 and S3). The G396R variant frequency was substantially enriched in SLE patients compared with that of criteria-matched controls in three independent cohorts from multiclinical centers in China (1786 healthy controls versus 1838 SLE patients in total, Pearson's chi-square test and binary logistic regression analysis, P = 6.0 × 10
−5
). Furthermore, the G396R variant was associated with a more severe disease phenotype, including earlier onset, multiple organ involvement, and higher SLE disease activity; specifically aggravated autoantibody production; and inflammation ( Fig. 1A and table S4 ). The variant drove an autoantibody subclass profile shift toward IgG1-isotype predominance in G396R patients (Fig. 1B) . Thus, hIgG1-G396R is a risk locus for SLE.
We generated knockin mice harboring the murine homolog mIgG1-G390R (denoted as Ighg1 T/T or G390R mice) (figs. S1C and S2, A and B). Under normal conditions, there were no significant differences in terms of natural antibodies or other evident phenotypes between wild-type (WT) and G390R mice ( fig. S2C ). In the bm12 splenocyte-inducible lupus model (12) , the levels of IgG1 subclass anti-double-stranded DNA (dsDNA), anti-Smith D (SmD), and antinuclear antibodies (ANA) were notably increased in G390R mice (Fig. 1, C and D, and fig. S3A ). Autoantigen microarrays further confirmed a clear increase in IgG1 but not IgM and IgG2b autoantibody production in G390R mice ( Fig.  1E and fig. S3B ). Moreover, G390R mice showed enlarged glomeruli and substantial IgG1 deposits containing ICs along with moderate IgG2b deposition (Fig. 1F) . Similar results were also observed in a second lupus model by using apoptotic thymocytes ( fig. S3 , C to E). In aged mice, the G390R variant facilitated autonomous IgG1 autoantibody production ( fig. S3F) . Thus, the G390R variant promotes autoantibody production during autoimmune disease progression.
Six weeks after the induction of autoimmunity with bm12 splenocytes, there was a fourfold increase in the number of IgG1 + germinal center (GC) B cells in G390R mice compared with that of WT mice ( Fig. 2A and fig. S4A ). IgG1 + memory B cells only mildly increased in G390R mice (Fig.  2B) . Notably, there was an almost sixfold increase in IgG1 + plasma cells in both the spleens and bone marrow of G390R mice (Fig. 2, C to E, and fig.  S4A ). This phenomenon was also seen in models of apoptotic thymocyte-induced lupus and aging ( fig. S4 , B and C). In a competitive model, in which WT or G390R B cells were adoptively transferred into B cell-deficient hosts ( fig. S4D ), more IgG1 + plasma cells were differentiated in the G390R group than in the WT group relative to the internal control. The competition index for the G390R group was 50% higher than that for the WT group ( fig. S4E ). Thus, increased B cell differentiation upon antigen stimulation, especially plasma cell generation, may be responsible for excessive autoantibody production in G390R mice. Positively charged amino acids in IgH complementarity-determining region 3 (CDR3) are associated with antibody autoreactivity (13) , and indeed, these types of amino acids were enriched in IgG1 + plasma cells from G390R mice compared with those from WT mice (Fig. 2F) . Moreover, the length of the Igg1 CDR3, which potentially predicts autoreactivity enrichments (2), was prominently increased in the G390R population ( fig. S4F ). We also observed reduced Ig variable (V) gene VH1 and joining (J) gene JH1 usage, but increased VH5, VH14, and JH4 usage in G390R IgG1 + plasma cells ( fig. S4G ). The enhanced antibody production by the hIgG1-G396R variant may also have effects on physiological humoral responses to non-self antigens. Thus, we conducted influenza vaccination experiments in healthy human WT controls and G396R homozygous carriers (Fig. 3A) . The G396R variant significantly potentiated the generation of influenza virus-specific IgG1 (Fig. 3B ) and only showed a relative minor effect on IgG2 production. We also confirmed these effects in 4-hydroxy-3-nitrophenylacetyl (NP) eight-keyhole limpet hemocyanin (KLH)-immunized mice (Fig.  3C) . NP-specific IgG1 antibody responses were almost twofold higher in G390R mice and threefold higher during antigen recall responses (Fig.  3D) . Affinity maturation did not appear to be significantly affected ( fig. S4H ). The increase in antibody production was in line with the enhanced numbers of NP-specific IgG1 + GC B and plasma cells in G390R mice (Fig. 3, E and F) . Thus, this variant enhances antibody production in both autoimmune disorders and in physiological humoral responses upon vaccination.
Because IgG1 + light-zone GC B cells in bm12-induced G390R mice up-regulated plasma cell fate favoring transcription profiles (Fig. 4A) , we then investigated the membrane-proximal signaling upon B cell activation (8, 14) . BCR microcluster formation, the synaptic recruitment of Grb2 and Btk, calcium mobilization, and the phosphorylation of downstream signaling molecules [Erk, S6, and nuclear factor-kB (NF-kB)] were significantly enhanced, indicating heightened signaling mediated by the variant (Fig. 4, B and C,  and fig. S5 , A to H). This effect was also observed in IgG1
+ primary B cells from the peripheral blood of G396R homozygotes compared with those from WT SLE patients (Fig. 4D and fig. S5, I and J) .
In a fluorescence resonance energy transfer (FRET)-based phospho-ITT activation reporter ( fig. S6 , A to C), G390R variants showed significantly higher FRET ratio changes compared with WT upon antigen stimulation (Fig. 4E) . Thus, the G390R variant promotes the activation of the phospho-ITT-Grb2 signaling module. Additional single-molecule imaging experiments revealed a more confined Grb2 motion in the immunological synapse of the G390R variant compared with that of WT primary B cells (Fig.  4F) . Thus, two potential models were proposed to explain the excessive activation of phospho-ITT-Grb2 signaling module: Increased Grb2 binding to the phospho-ITT motif and/or increased ITT-motif phosphorylation. Isothermal titration calorimetry assays demonstrated similar binding between the Grb2 protein and either the WT or G390R phospho-ITT motif peptide ( fig. S7A ). In the second model, both Syk and Lyn tyrosine kinases are involved in the phosphorylation of the ITT motif (11). G390R ITT phosphorylation by Syk was only mildly higher ( fig. S7 , B and C). Substantially enhanced phosphorylation of the G390R ITT motif by Lyn was observed in vitro ( Fig. 4G and fig. S7D ) and in vivo ( fig. S7E) .
Finally, to identify the structural basis for excessive G390R ITT motif phosphorylation by Lyn, we carried out molecular dynamics simulations of the Lyn kinase domain bound to either the WT or the G390R ITT motif. We constructed complex models of substrate peptide and kinase domain based on the structure of the active human Lyn kinase domain (Protein Data Bank 3A4O) (15) 
) and G390R mice (n = 3). Unpaired two-tailed Student's t tests, (A) to (E). Two-way ANOVA, (F). Bars indicate means.
Representative data are from at least two independent experiments in (A) to (F).
trajectory. Additionally, the Asp-Phe-Gly (DFG) motif and aC helix of the Lyn kinase domain were maintained in an active conformation ( Fig.  4H and fig. S7, F and G) . Notably, the Arg 390 residue in the G390R ITT motif formed an additional hydrogen bond with the backbone carbonyl of Asn 290 in Lyn kinase domain, which was not available for the Gly 390 residue in the WT ITT motif (Fig. 4H) . Furthermore, the distance between the hydroxyl group of catalytic residue Tyr 385 and g-phosphate group of adenosine triphosphate (ATP) was significantly shorter for the G390R variant than for WT (Fig. 4I and  fig. S7H ), suggesting more stable contacts and potentially more effective phosphotransfer for the G390R variant. Indeed, the binding free energy of the G390R variant was consistently lower than that of the WT ITT motif (Fig. 4H) . Together, these computational results suggest the higher binding ability of the G390R variant to active Lyn kinase.
The G390R variant potentiates ITT-motif phosphorylation and alters the availability of the phospho-ITT motif, thereby triggering a significantly longer dwell time of Grb2 in the immunological synapse. This, in turn, changes the synaptic Grb2 recruitment from a "recruit-and-escape" model to a "recruit-and-confine" model, in which the initially recruited but subsequently escaped Grb2 can be recaptured by the proximal phospho- (20) . Thus, we contend that IgG-BCR not only promotes enhanced memory responses but also leads to the development and relapse of autoimmune diseases when dysregulated.
